Imexpharm Corporation hereby announces the time, agenda, Proposal to collect written opinions from the General Meeting of Shareholders (“GMS”), voting slip, draft Resolution of the GMS, and other documents to collect written opinions from the GMS as follows:
- Timeline for collecting shareholders' written opinions: from November 27, 2023 to December 18, 2023.
- Deadline for aggregating opinions and counting votes: expected December 19, 2023.
- Agenda and GMS Documents: have been already posted and available for download on the Company’s website at:
https://imexpharm.com/uploads/20231127-imp-18-2023-tai-lieu-lay-y-kien-co-dong-bang-van-ban.pdf